FMO5 and atherosclerosis: Gray and colleagues (10) previously suggested that genetic deletion of Nox2 was potentially lethal and that the Nox1 isoform of NADPH oxidase was a more appropriate target to slow the development of atherosclerosis in diabetic mice.